NO851938L - Fremgangsmaate ved fremstilling av et ftalazinonderivat. - Google Patents

Fremgangsmaate ved fremstilling av et ftalazinonderivat.

Info

Publication number
NO851938L
NO851938L NO851938A NO851938A NO851938L NO 851938 L NO851938 L NO 851938L NO 851938 A NO851938 A NO 851938A NO 851938 A NO851938 A NO 851938A NO 851938 L NO851938 L NO 851938L
Authority
NO
Norway
Prior art keywords
compound
hydrogen
formula
phthalazinone
ethenyl
Prior art date
Application number
NO851938A
Other languages
English (en)
Norwegian (no)
Inventor
Telfer Lawson Thomas
Lesley Ann Radov
Original Assignee
Pennwalt Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pennwalt Corp filed Critical Pennwalt Corp
Publication of NO851938L publication Critical patent/NO851938L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30—Phthalazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30—Phthalazines
    • C07D237/32—Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO851938A 1984-05-17 1985-05-14 Fremgangsmaate ved fremstilling av et ftalazinonderivat. NO851938L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/611,310 US4665181A (en) 1984-05-17 1984-05-17 Anti-inflammatory phthalazinones

Publications (1)

Publication Number Publication Date
NO851938L true NO851938L (no) 1985-11-18

Family

ID=24448523

Family Applications (1)

Application Number Title Priority Date Filing Date
NO851938A NO851938L (no) 1984-05-17 1985-05-14 Fremgangsmaate ved fremstilling av et ftalazinonderivat.

Country Status (14)

Country Link
US (1) US4665181A (de)
EP (1) EP0164593B1 (de)
JP (1) JPS60255777A (de)
KR (1) KR850008668A (de)
AT (1) ATE47998T1 (de)
AU (1) AU570549B2 (de)
DE (2) DE3574253D1 (de)
DK (1) DK215485A (de)
FI (1) FI851959L (de)
IL (1) IL74805A (de)
NO (1) NO851938L (de)
NZ (1) NZ211589A (de)
PH (1) PH23246A (de)
ZA (1) ZA852387B (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3575135D1 (de) * 1984-09-14 1990-02-08 Asta Pharma Ag Substituierte benzylphthalazinon-derivate.
US4769369A (en) * 1986-11-14 1988-09-06 Pennwalt Corporation Anti-allergy 1(2H)-phthalazinones
EP0309765A3 (de) * 1987-09-30 1990-09-26 Fisons Corporation 1(2H)-Phthalazinone als zytoprotektive Arzneimittel
DE4103405A1 (de) * 1991-02-05 1992-08-06 Basf Ag 3-amino-benzol-1,2,4,5-tetracarbonsaeuredihydrazide und ihre verwendung als chemilumineszenz-faehige verbindugnen sowie 3-amino-benzol-1,2,4,5-tetracarbonsaeuredianhydride
DE4207234A1 (de) * 1992-03-07 1993-09-09 Asta Medica Ag Neue aminocarbonsaeure-derivate mit antiallergischer/antiasthmatischer wirkung und verfahren zu deren herstellung
CH683965A5 (it) * 1993-02-19 1994-06-30 Limad Marketing Exp & Imp Composti della classe dei ftalidrazidici come sostanza attiva in agenti antinfiammatori ed antitossici.
EP0934933A1 (de) * 1998-02-06 1999-08-11 Byk Gulden Lomberg Chemische Fabrik GmbH Phthalazinone
PT1165085E (pt) * 1999-03-30 2006-10-31 Novartis Ag Derivados de ftalazina para tratar doencas inflamatorias
DK1246813T3 (da) * 1999-12-30 2004-03-01 Lundbeck & Co As H Fremgangsmåde til fremstilling af Citalopram
US7151102B2 (en) * 2000-10-30 2006-12-19 Kudos Pharmaceuticals Limited Phthalazinone derivatives
GB0111078D0 (en) * 2001-05-04 2001-06-27 Novartis Ag Organic compounds
AU2003229953A1 (en) * 2002-04-30 2003-11-17 Kudos Pharmaceuticals Limited Phthalazinone derivatives
GB0223341D0 (en) * 2002-10-08 2002-11-13 Groningen Acad Ziekenhuis Organic compounds
GB0305681D0 (en) 2003-03-12 2003-04-16 Kudos Pharm Ltd Phthalazinone derivatives
US7449464B2 (en) * 2003-03-12 2008-11-11 Kudos Pharmaceuticals Limited Phthalazinone derivatives
GB0419072D0 (en) * 2004-08-26 2004-09-29 Kudos Pharm Ltd Phthalazinone derivatives
EP2522365B1 (de) 2004-11-24 2016-10-26 Meda Pharmaceuticals Inc. Zusammensetzungen aus Azelastin und Verwendungsverfahren dafür
US8758816B2 (en) 2004-11-24 2014-06-24 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
US20070020330A1 (en) 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
GB0428111D0 (en) * 2004-12-22 2005-01-26 Kudos Pharm Ltd Pthalazinone derivatives
US7759337B2 (en) * 2005-03-03 2010-07-20 Amgen Inc. Phthalazine compounds and methods of use
WO2006103550A1 (en) * 2005-03-31 2006-10-05 Ranbaxy Laboratories Limited Processes for the preparation of citalopram and its intermediate 5-aminophthalide
GB0521373D0 (en) 2005-10-20 2005-11-30 Kudos Pharm Ltd Pthalazinone derivatives
US20090281086A1 (en) * 2006-06-15 2009-11-12 Kudos Pharmaceuticals Limited 2 -oxyheteroarylamide derivatives as parp inhibitors
EP2041087A1 (de) * 2006-06-15 2009-04-01 Kudos Pharmaceuticals Limited 2-oxybenzamidderivate ls parp-inhibitoren
WO2007144652A2 (en) * 2006-06-15 2007-12-21 Kudos Pharmaceuticals Limited Parp inhibitors
GB0619325D0 (en) 2006-09-30 2006-11-08 Univ Strathclyde New compounds
UY30639A1 (es) * 2006-10-17 2008-05-31 Kudos Pharm Ltd Derivados sustituidos de 2h-ftalazin-1-ona, sus formas cristalinas, proceso de preparacion y aplicaciones
US20080280910A1 (en) * 2007-03-22 2008-11-13 Keith Allan Menear Phthalazinone derivatives
TW200900396A (en) * 2007-04-10 2009-01-01 Kudos Pharm Ltd Phthalazinone derivatives
US20090023727A1 (en) * 2007-07-05 2009-01-22 Muhammad Hashim Javaid Phthalazinone derivatives
JP2010539149A (ja) 2007-09-14 2010-12-16 アストラゼネカ アクチボラグ フタラジノン誘導体
JP5593229B2 (ja) * 2007-10-17 2014-09-17 クドス ファーマシューティカルズ リミテッド ４−［３−（４−シクロプロパンカルボニル−ピペラジン−１−カルボニル）−４−フルオロ−ベンジル］−２ｈ−フタラジン−１−オン
AR070221A1 (es) 2008-01-23 2010-03-25 Astrazeneca Ab Derivados de ftalazinona inhibidores de polimerasas, composiciones farmaceuticas que los contienen y usos de los mismos para prevenir y/o tratar tumores cancerigenos,lesiones isquemicas y otras enfermedades asociadas.
ES2598178T5 (es) 2008-10-07 2023-12-26 Kudos Pharm Ltd Formulación farmacéutica 514
UY32790A (es) * 2009-07-15 2011-02-28 Astrazeneca Ab Compuesto de ftalazinona
ES2648820T3 (es) * 2011-05-10 2018-01-08 Gilead Sciences, Inc. Compuestos heterocíclicos condensados como moduladores de los canales de sodio
US9783529B2 (en) 2013-03-13 2017-10-10 Flatley Discovery Lab, Llc Pyridazinone compounds and methods for the treatment of cystic fibrosis

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB808636A (en) * 1955-08-02 1959-02-11 Cassella Farbwerke Mainkur Ag Basically substituted heterocyclic compounds
GB1126669A (en) * 1967-04-28 1968-09-11 Deutsches Hydrierwerke Rodlebe Process for production of basically substituted phthalazones
DE2114884A1 (de) * 1971-03-27 1972-10-12 Cassella Farbwerke Mainkur Ag, 6000 Frankfurt Basisch substituierte Derivate des 1(2H)-Phthalazinons
JPS4931683A (de) * 1972-07-27 1974-03-22
JPS5214788A (en) * 1975-07-21 1977-02-03 Fuji Photo Film Co Ltd Process for preparing phthalazinone and its derivatives
US4134880A (en) * 1978-01-19 1979-01-16 Mitsui Toatsu Chemicals, Incorporated Process for producing an aromatic urethane from nitro compounds, hydroxyl compounds and carbon monoxide using metal-Lewis acid-ammonia catalyst systems
US4334069A (en) * 1978-07-24 1982-06-08 Miles Laboratories, Inc. Chemiluminescent phthalhydrazide-labeled hapten conjugates
US4293553A (en) * 1978-08-11 1981-10-06 Masayuki Ishikawa 1-Phthalazone derivatives, and use thereof
CA1143733A (en) * 1979-07-31 1983-03-29 Masao Yoshida Producing 7-alkoxycarbonyl-6,8-dimethyl-4- hydroxymethyl-1-phthalazone and intermediates

Also Published As

Publication number Publication date
FI851959A7 (fi) 1985-11-18
IL74805A0 (en) 1985-07-31
DE3574253D1 (de) 1989-12-21
EP0164593B1 (de) 1989-11-15
DK215485A (da) 1985-11-18
NZ211589A (en) 1988-06-30
JPS60255777A (ja) 1985-12-17
AU570549B2 (en) 1988-03-17
DE164593T1 (de) 1986-06-12
IL74805A (en) 1988-07-31
EP0164593A1 (de) 1985-12-18
US4665181A (en) 1987-05-12
AU4087385A (en) 1985-11-21
KR850008668A (ko) 1985-12-21
FI851959A0 (fi) 1985-05-16
ZA852387B (en) 1986-04-30
FI851959L (fi) 1985-11-18
ATE47998T1 (de) 1989-12-15
PH23246A (en) 1989-06-16
DK215485D0 (da) 1985-05-15

Similar Documents

Publication Publication Date Title
NO851938L (no) Fremgangsmaate ved fremstilling av et ftalazinonderivat.
SU1480770A3 (ru) Способ получени пирроло-бензимидазолов или их физиологически совместимых солей с неорганическими кислотами
CA1192546A (en) Substituted 1h-pyrazolo¬1,5-a|pyrimidines and process for their preparation
JP2002521371A (ja) ホスホジエステラーゼ４阻害剤としてのフタラジン誘導体
NO154346B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive ftalazin-4-yl-eddiksyrederivater.
US5880122A (en) 3-Carboxamide derivatives of 5H-pyrrolo 2,1-c! 1,4!-benzodiazepines
DE3533331A1 (de) Pyridothiazolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
JP2002521370A (ja) フタラジン誘導体ホスホジエステラーゼ４阻害剤
IL42799A (en) Carbazolic history of alcohols, sites and alkanoic acids, their preparation and pharmaceutical preparations containing signal
JP2001503759A (ja) ５Ｈ―ピロロ［２，１―ｃ］［１，４］ベンゾジアゼピンの３―カルボキサミド誘導体
CA1084929A (en) 1,2,4-triazolo 4,3-b pyridazin-3-ones
NO173185B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinoxalinforbindelser
CA2128871A1 (en) Pyrazolopyrimidin derivatives as angiotensin ii receptor antagonists
US4183932A (en) Fused quinazolinones and preparation thereof
US5389632A (en) Pyrazolopyrimidine derivatives which are angiotensin II receptor antagonists
NL8202706A (nl) Gesubstitueerde thiazolo3,2-apyrimidinen en werkwijzen ter bereiding ervan.
US4442289A (en) 4-Oxothieno[3,2-d]pyrimidine acetic acid esters
US4053600A (en) Tricyclic 1,2,4-triazolo-quinazolines
JPH05125079A (ja) ピラゾロ［１，５−ａピリミジン誘導体
Ho et al. Inhibitors of Monoamine Oxidase III: 9-Substituted-β-Carbolines
JPS6031823B2 (ja) カルバゾ−ル誘導体の製造方法
von Strandtmann et al. Acyltryptamines. II. Synthesis of Acyltryptamines, Indazoles, and Azepinoindoles from the Acylphenylhydrazones of 2, 3-Piperidinedione1
SU1355131A3 (ru) Способ получени замещенных производных карбокситиазоло[3,2-а]пиримидина или их фармацевтически приемлемых солей
GB2116971A (en) 1H-pyrazolo [1,5-a] pyrimidines
DK151811B (da) Analogifremgangsmaade til fremstilling af n-(5-tetrazolyl)-1-oxo-1h-thiazolooe3,2-aaa-pyrimidin-2-carboxamider eller farmaceutisk acceptable kationsalte deraf samt 1-oxo-1h-thiazolooe3,2-aaapyrimidin-2-carboxylsyrer til anvendelse som udgangsmaterialer ved fremgangsmaaden